TerrAscend Corp. (OTCMKTS:TSNDF - Free Report) - Analysts at Seaport Res Ptn issued their Q1 2026 earnings per share (EPS) estimates for shares of TerrAscend in a research report issued to clients and investors on Sunday, March 9th. Seaport Res Ptn analyst S. Randhawa anticipates that the company will post earnings of ($0.03) per share for the quarter. The consensus estimate for TerrAscend's current full-year earnings is ($0.14) per share. Seaport Res Ptn also issued estimates for TerrAscend's Q2 2026 earnings at ($0.03) EPS, Q3 2026 earnings at ($0.03) EPS and Q4 2026 earnings at ($0.03) EPS.
TerrAscend (OTCMKTS:TSNDF - Get Free Report) last released its earnings results on Thursday, March 6th. The company reported $0.01 EPS for the quarter, topping the consensus estimate of ($0.03) by $0.04. TerrAscend had a negative return on equity of 31.48% and a negative net margin of 23.95%. The business had revenue of $74.35 million for the quarter, compared to the consensus estimate of $72.37 million.
Separately, Atb Cap Markets cut shares of TerrAscend from a "strong-buy" rating to a "hold" rating in a report on Monday, December 9th.
View Our Latest Analysis on TerrAscend
TerrAscend Stock Performance
Shares of TSNDF stock opened at $0.45 on Tuesday. The company has a market capitalization of $131.90 million, a price-to-earnings ratio of -1.61 and a beta of 1.64. The company has a debt-to-equity ratio of 0.81, a quick ratio of 0.69 and a current ratio of 1.35. TerrAscend has a one year low of $0.38 and a one year high of $2.20. The company's 50-day moving average is $0.57 and its 200 day moving average is $0.85.
About TerrAscend
(
Get Free Report)
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider TerrAscend, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TerrAscend wasn't on the list.
While TerrAscend currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
